Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesImpact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain
Current Medical Research and Opinion, 06/17/09
Boulanger L et al. - The study identified 11854 DPNP-only and 1512 DPNP-DA patients in the Medicare supplemental cohort, and 11685 and 2728 in the commercially insured cohort. Compared to DPNP-only patients over the follow-up period, a significantly higher percentage of DPNP-DA patients were dispensed pain and DPNP-related medication. All components of healthcare utilization, except home healthcare visits and physician office visits, were more likely to be provided to DPNP-DA patients versus the DPNP-only cohort. Controlling for differences in demographic and clinical characteristics, DPNP-DA patients had significantly higher total costs than those of DPNP-only patients for Medicare and commercially insured patients. Due to the use of a retrospective administrative claims database, limitations of this study include the potential for selection bias between study cohorts, mis-identification of DPNP and/or depression, and inability to assess indirect costs as well as use and cost of over-the-counter medications. These findings indicate that the healthcare costs were significantly higher for DPNP patients comorbid with depression and/or anxiety relative to those without such disorders.
Related Articles
Impact of Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy on Health Care Costs
The Journal of Pain, 10/26/09
Relevance Score: 88%
Duloxetine for treating painful neuropathy or chronic pain
Cochrane Reviews, 10/08/09
Relevance Score: 88%
Neuropathic pain: Peripheral and central mechanisms
European Journal of Pain, 11/12/09
Relevance Score: 84%
The pharmacological treatment of neuropathic pain
European Journal of Pain, 11/12/09
Relevance Score: 81%
Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State
Journal of Opioid Management, 11/03/09
Relevance Score: 81%
Today in Pharmacoeconomics...keeping you current
Receive free subspecialty "5-minute updates" via email
Economic consequences of ACS-related rehospitalizations in the US
Current Medical Research and Opinion, 12/10/09
Out-of-pocket Prices of Opioid Analgesics in the United States, 1999–2004
Pain Medicine, 12/10/09
The Impact of Disposables on Project Economics in a New Antibody Plant
BioPharm, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor